<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29415" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Sputum Analysis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shen</surname>
            <given-names>Fan</given-names>
          </name>
          <aff>University of Alberta</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sergi</surname>
            <given-names>Consolato</given-names>
          </name>
          <aff>University of Alberta</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fan Shen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Consolato Sergi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29415.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Mucus is the fluid secreted by the airways (bronchial tubes and windpipes) and lungs. The term phlegm is also used in the context of an infection or chronic health condition. The mixture of saliva and mucus specifically coughed up from the respiratory tract, often following an infection or irritation of the mucosa, is precisely labeled sputum. The term phlegm arises from the Greek word <italic toggle="yes">&#x003d5;&#x003bb;&#x003b3;&#x003bc;&#x003b1;</italic>, which was used in the ancient books of medicine to label humor caused by heat.</p>
        <p>Sputum is examined grossly and microscopically to aid medical diagnosis. The sputum&#x000a0;contains various cells and molecular compounds, such as&#x000a0;soluble&#x000a0;lipids and proteins, making its analysis critical in medicine. The sputum analysis involves an analytical approach to investigate the cellular and acellular components expelled from&#x000a0;the patient's upper respiratory tract.&#x000a0;This procedure is essential in evaluating and managing lower respiratory infections&#x000a0;or other longstanding health conditions.<xref ref-type="bibr" rid="article-29415.r1">[1]</xref>&#x000a0;Clinically, sputum molecular biomarkers or gene sequencing of the microorganisms have increased medicine accuracy and represent a milestone in the current evaluations of the algorithms running for precision medicine.</p>
      </sec>
      <sec id="article-29415.s2" sec-type="Specimen Requirements and Procedure">
        <title>Specimen Requirements and Procedure</title>
        <p>Sputum specimen collection is typically a noninvasive and&#x000a0;straightforward procedure. However, in some clinical settings, a more intensive approach may be necessary when patients have difficulty expelling fluid from the upper respiratory tract. In such cases, some physiotherapy maneuvers may be considered adjuvant to get some material for the analysis. A deep cough sample, often collected early in the morning before eating or drinking, helps reduce potential biases in test results. First, the patient should&#x000a0;rinse their mouth&#x000a0;with clear water for 10&#x000a0;to 15 seconds to eliminate contaminants in the oral cavity. After expelling saliva, the patient should take 3 deep breaths and then cough at 2-minute intervals&#x000a0;until bringing up some sputum. The sputum is then collected in a sterile, sealed container provided by the medical professionals.</p>
        <p>The medical professionals assess&#x000a0;the volume and quality of the sputum, which should be thick to facilitate proper laboratory investigation. In several institutions, clear and runny samples are&#x000a0;unacceptable for further microscopic or microbiological studies. In some cases, collection may be repeated until 10 to 20 mL of sputum is obtained. Changing the lid of the collection container after the initial sample helps prevent contamination. If the patient has trouble producing enough sputum, the medical professionals may use some physiotherapeutic maneuvers, which allow&#x000a0;the&#x000a0;progressive release of the sputum. For routine sputum cultures, a single sample is collected and sent to the lab on the same day of collection. If the patient leaves the specimen in the refrigerator after collection, there is often a tolerance range, which may run well over 24 hours. In tuberculosis,&#x000a0;3 sputum samples must be collected on&#x000a0;3 consecutive days and returned to the clinical lab daily.</p>
        <p>
<bold>Sputum Induction</bold>
</p>
        <p>Sputum induction<bold>&#x000a0;</bold>is a procedure used to collect adequate lower respiratory&#x000a0;secretions from patients who have difficulty producing sputum,&#x000a0;aiding in the diagnosis of tuberculosis. This procedure is essential for patients suspected of having miliary tuberculosis or tuberculous pleural effusion. The patient inhales a nebulized hypertonic saline solution to liquefy airway secretions, stimulating coughing and promoting the expectoration of mucus. The medical professionals prepare a 20 mL 3% hypertonic saline solution&#x000a0;and inject it into the water-filled nebulizer cup. Similar to the non-adjuvant procedure, the patients must always wash their mouths thoroughly.</p>
        <p>Moreover, after sitting upright, the patients wear the nebulizer cup to cover the face and nose.&#x000a0;The patients inhale and exhale through the mouthpiece. An expectorate saliva is placed into an emesis bowl, and expectorate sputum coughed up is collected into a sterile, sealed container. The medical staff turns on the&#x000a0;nebulizer device to allow the patient to inhale the hypertonic mist for approximately&#x000a0;5 minutes. Then, the patients take several deep breaths before attempting to cough. If patients have difficulty producing sputum, the medical staff may use gentle chest physiotherapy to aid the patients in producing sputum. During the procedure, close observation by medical staff is essential to monitor for potential complications, such as the potential rupture of pleural bullae, which can lead to a life-threatening pneumothorax.&#x000a0;The procedure should be stopped when a 1 to 2 mL sputum specimen is collected, after 15 minutes of nebulization, or if the patient complains of chest tightness, dyspnea, or wheezing.&#x000a0;Imaging is advised if these symptoms persist at the end of the sputum collection.</p>
        <p>
<bold>Bronchoscopy</bold>
</p>
        <p>Bronchoscopy is used to visualize the throat and airway through a thin lighting&#x000a0;camera. This technique can also be used to collect sputum samples in special situations, such as a persistent infection, cough, or unusual findings in clinical laboratory tests or chest X-rays. The sputum specimen is examined under a microscope to detect the presence of abnormal cells. Flexible bronchoscopy is used more often&#x000a0;compared to rigid bronchoscopy to collect the sputum samples. Before undergoing a flexible bronchoscopy, the clinician may administer an anesthetic&#x000a0;to relax the throat muscles and numb the mouth, nasal passages, or throat. The procedure uses a thin and lighted&#x000a0;bronchoscope inserted through the mouth or nose, down to the throat into the windpipe (trachea), and then to the major bronchi leading to the lungs. Sputum&#x000a0;samples&#x000a0;can be collected using instruments passed through the bronchoscope by the clinician.</p>
      </sec>
      <sec id="article-29415.s3" sec-type="Diagnostic Tests">
        <title>Diagnostic Tests</title>
        <p>Clinical diagnostic sputum tests aim to detect the causes of lower respiratory tract infections&#x000a0;and other diseases, serving as a valuable tool for monitoring&#x000a0;the effectiveness of clinical treatment.&#x000a0;Sputum culture is the most common test performed when the&#x000a0;patient has pneumonia, as it&#x000a0;helps identify the bacteria or&#x000a0;fungi causing the airway or lung infection.</p>
        <p>Sputum smear microscopy is the initial step in laboratory sputum analysis. This fast and cost-effective technique is beneficial in resource-limited settings. The Gram stain&#x000a0;is the initial staining technique performed&#x000a0;in preliminary bacterial identification, which&#x000a0;helps determine whether there is an adequate amount of pathogens in the culture, making it a definitive diagnosis. This technique is also crucial because it can address antibiotic therapy more specifically. The Gram stain distinguishes the bacterial species into gram-positive and gram-negative groups based on the differences in their cell walls' physical and chemical properties.</p>
        <p>Gram-positive bacteria have a thick peptidoglycan layer in their cell walls stained with crystal violet. In contrast, gram-negative bacteria have a thinner&#x000a0;peptidoglycan layer stained red or pink&#x000a0;with a counterstain.<xref ref-type="bibr" rid="article-29415.r2">[2]</xref> When tuberculosis is suspected,&#x000a0;acid-fast bacilli (AFB) stain testing must be&#x000a0;performed. Tuberculosis&#x000a0;is&#x000a0;a lung infection caused by <italic toggle="yes">Mycobacterium tuberculosis</italic>. Mycobacteria&#x000a0;are a group of rod-shaped AFB. These bacteria can be distinguished&#x000a0;under the microscope after&#x000a0;an AFB staining procedure where the bacilli retain the stain color after an acid-fast wash. The Grocott-Gomori's methenamine silver stain (GMS) is a standard staining method used to detect fungal microorganisms, especially <italic toggle="yes">Pneumocystis jirovecii</italic>,<italic toggle="yes">&#x000a0;</italic>which was first identified in patients with human&#x000a0;HIV infection in the 1980s, and it was&#x000a0;used to be classified as a protozoan.&#x000a0;This microorganism, now classified as a fungus,&#x000a0;was initially called&#x000a0;<italic toggle="yes">Pneumocystis carinii</italic>.&#x000a0;Colony morphology is a method that describes the characteristics of an individual colony of bacteria growing on agar in a Petri dish. This method can&#x000a0;help the lab technologist to identify some specific bacteria.&#x000a0;</p>
        <p>However, relying only on microscopic observation and colony morphology may not be enough to get the relevant information about the species and genus of etiologic microorganisms. Biochemical tests of bacterial growth are the next step in recognizing bacteria. The standard biochemical tests used to identify bacterial growth include fluid thioglycollate medium, catalase, and&#x000a0;oxidase tests.&#x000a0;</p>
        <p>Respiratory viruses can be detected in sputum specimens&#x000a0;from patients with cystic fibrosis, asthma, and chronic obstructive pulmonary disease.<xref ref-type="bibr" rid="article-29415.r3">[3]</xref><xref ref-type="bibr" rid="article-29415.r4">[4]</xref><xref ref-type="bibr" rid="article-29415.r5">[5]</xref>&#x000a0;Viral testing is typically performed on upper airway samples&#x000a0;such as nasopharyngeal swabs or nasal washes. However, some&#x000a0;viral pathogens such as&#x000a0;severe acute respiratory syndrome (SARS) coronavirus,&#x000a0;H1N1 influenza, Middle Eastern respiratory syndrome coronavirus (MERS-CoV), and SARS coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, may be absent in upper airway secretions.<xref ref-type="bibr" rid="article-29415.r6">[6]</xref><xref ref-type="bibr" rid="article-29415.r7">[7]</xref><xref ref-type="bibr" rid="article-29415.r8">[8]</xref><xref ref-type="bibr" rid="article-29415.r9">[9]</xref> Consequently,&#x000a0;sputum samples are frequently&#x000a0;used for viral diagnosis testing using real-time&#x000a0;polymerase chain reaction (RT-PCR) or the newly developed next-generation sequencing (NGS) method. Potentially, face masks, which reduce the aerosol-related risk of transmission in the current era of the COVID-19 pandemic, may also represent a useful source for&#x000a0;NGS investigations.<xref ref-type="bibr" rid="article-29415.r10">[10]</xref></p>
        <p>Sputum cytology examination uses a microscope to&#x000a0;determine the presence of abnormal cells in sputum samples. The thin layer of sputum placed on a slide before specific staining and diagnosed directly under the microscope helps find some abnormal cells. Sputum cytology helps&#x000a0;detect lung cancer cells and non-cancer cellular and acellular materials useful for diagnosing&#x000a0;conditions such as pneumonia, tuberculosis,&#x000a0;interstitial lung diseases, or pneumoconiosis, for example, asbestosis. The hematoxylin and eosin stain is the most commonly performed tissue stain in medical laboratory diagnosis and is often considered the gold standard.<xref ref-type="bibr" rid="article-29415.r11">[11]</xref><xref ref-type="bibr" rid="article-29415.r12">[12]</xref>&#x000a0;This&#x000a0;stain is primarily used for samples suspected of lung cancer. The periodic acid&#x02013;Schiff stain is used to detect polysaccharides and mucosubstances in tissue specimens. This&#x000a0;stain is&#x000a0;mainly helpful for detecting living fungi in sputum specimens.</p>
        <p>Wright, Giemsa, and Wright-Giemsa mixture stains are commonly used for sputum smears, aiding in differentiating blood cell types through specific staining solutions. These methods are instrumental in detecting abnormal white blood cells in sputum, which are critical indicators of lung infections.</p>
        <p>Sputum molecular analysis is a&#x000a0;new&#x000a0;insight and advanced technique used&#x000a0;to detect lung cancer&#x02013;related biomarkers,&#x000a0;assisting in early-stage lung cancer&#x000a0;diagnosis. Many DNA mutations, such as&#x000a0;<italic toggle="yes">p53</italic>,<italic toggle="yes">&#x000a0;</italic><italic toggle="yes">KRAS</italic>,<italic toggle="yes">&#x000a0;EML4-ALK</italic>,<italic toggle="yes">&#x000a0;</italic>and<italic toggle="yes">&#x000a0;GFR</italic>, have been investigated on sputum specimens.<xref ref-type="bibr" rid="article-29415.r13">[13]</xref><xref ref-type="bibr" rid="article-29415.r14">[14]</xref><xref ref-type="bibr" rid="article-29415.r15">[15]</xref>&#x000a0;DNA hypermethylation has also been reported&#x000a0;in lung cancer sputum samples. Loss of heterozygosity and microsatellite instability have been found&#x000a0;in sputum specimens of&#x000a0;lung cancer patients using DNA markers.<xref ref-type="bibr" rid="article-29415.r16">[16]</xref>&#x000a0;MicroRNAs, such as miR-21 and miR-155, and proteins, such as proliferation-inducing ligand (APRIL) and complement factor H, were significantly overexpressed. Some messenger RNAs, such as <italic toggle="yes">APRIL</italic>,<italic toggle="yes"> MAGE</italic>, <italic toggle="yes">Telomerase</italic>,&#x000a0;and <italic toggle="yes">CEA</italic>,&#x000a0;have been found to rapidly degrade in the sputum specimens of lung cancer patients, as detected by RT-PCR and&#x000a0;immunocytochemistry.<xref ref-type="bibr" rid="article-29415.r17">[17]</xref>&#x000a0;Still, other molecular biomarkers, such as free and mitochondrial DNA variants, appear promising.<xref ref-type="bibr" rid="article-29415.r17">[17]</xref></p>
        <p>Finally, sputum antimicrobial susceptibility testing&#x000a0;is performed on the&#x000a0;bacteria or fungi identified in sputum cultures to determine effective treatment options. The most common approaches include&#x000a0;the disk diffusion and minimum inhibitory concentration (MIC) methods.&#x000a0;These tests are&#x000a0;used to detect&#x000a0;the effectiveness of the specific antibiotics on the bacteria or to detect whether&#x000a0;the bacteria have already developed resistance to certain antibiotics. Antimicrobial susceptibility testing results help select the most likely effective antibiotics&#x000a0;in treating lung&#x000a0;infections.</p>
      </sec>
      <sec id="article-29415.s4" sec-type="Testing Procedures">
        <title>Testing Procedures</title>
        <p>
<bold>Sputum Culture Procedure</bold>
</p>
        <p>The sputum sample is added to a culture plate containing a medium that promotes bacterial or fungal growth. The plate is covered and&#x000a0;incubated at&#x000a0;37 &#x000b0;C for bacterial growth and 30 &#x000b0;C for fungal growth. The lab specialist should check bacterial or fungal growth in the sputum plate daily. Once the sputum culture is positive, further tests, such as microscopy, colony morphology assessment, and biochemical testing, are performed to identify the specific bacterium or fungus.</p>
        <p>
<bold>Sputum Staining Test Procedure</bold>
</p>
        <p>A smear of the sputum specimen is prepared on a microscope slide. Various staining dyes are applied to the cells, bacteria, or fungi on the slide, followed by rinsing with water, alcohol, or acid solutions. The slide is then examined under a microscope, and results are considered positive if bacteria, fungi, or specific cell types are identified.</p>
        <p>
<bold>Sputum Biochemical Test Procedure</bold>
</p>
        <p>Bacteria are first inoculated in a series of differential media to identify a suspected organism. Then, different indicators are used to observe the specific end products of metabolism inside the medium.&#x000a0;</p>
        <p>
<bold>Sputum Cytology Examination Procedure</bold>
</p>
        <p>The smear sputum slide is stained with different dyes according to the instructions.&#x000a0;A pathology specialist examines the stained slide under a microscope to detect the abnormal cells from the sputum specimen.&#x000a0;</p>
        <p>
<bold>Sputum Nucleic Acid Amplification Test Procedure</bold>
</p>
        <p>RNA or DNA is extracted from the sputum specimen following the instructions provided by different commercial kits. The DNA or RNA is added to a PCR reaction tube with designed primers,&#x000a0;<italic toggle="yes">Taq</italic>&#x000a0;polymerase, deoxynucleoside triphosphates, and a fluorescent-labeled probe. The tube with the RT-PCR reaction mixture is then placed in a real-time PCR device to amplify&#x000a0;the molecules at specific temperatures.&#x000a0;</p>
        <p>
<bold>Sputum Antimicrobial Susceptibility Test Procedure</bold>
</p>
        <p>For the MIC method, the bacteria or fungi isolated from sputum specimens were&#x000a0;diluted in saline and swabbed onto&#x000a0;the&#x000a0;MIC panels. Different antibiotic concentrations are placed directly onto the bacteria-swabbed agar plates for the dish diffusion method. Panels or plates are incubated at 35&#x000a0;&#x000b0;C for&#x000a0;about 16&#x000a0;to 18 hours or longer. The minimal concentration of the antibiotic that inhibits&#x000a0;the growth of organisms, known as the MIC, is read according to&#x000a0;the guidelines of various&#x000a0;manufacturers. The results are then documented and reported.</p>
      </sec>
      <sec id="article-29415.s5" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>Various factors can interfere with the results at each stage of sputum diagnosis. Any deviation from the standard procedure of sample collection, culture, staining, biochemical, molecular, and antimicrobial susceptibility tests can significantly impact the diagnostic result, directly&#x000a0;affecting the patient's clinical management. Therefore, strict laboratory workflow procedures and&#x000a0;well-trained laboratory technologists are required to perform the sputum analysis.</p>
        <p>Obtaining a high-quality sputum sample is crucial for accurate diagnosis. If the specimen is transparent, laboratory technologists may not find the pathogens or cells related to the disease. Moreover, pathogens identified from sputum culture do not always originate from lower respiratory tract infections because they may be part of contaminant sites or preexist&#x000a0;in the oral flora. Thus, standard microbiological procedures for organism isolation and identification&#x000a0;are critical for the sputum quality assessment.</p>
        <p>Quality assurance is essential for distinguishing the actual&#x000a0;respiratory pathogens from the possible colonizing flora. The quality of commercial laboratory products&#x02014;such as culture plates, staining kits, and molecular biology kits&#x02014;must meet approval standards from regulatory bodies such as the United States Food and Drug Administration (FDA), the Public Health Agency of Canada, and similar agencies in Europe and Australia. Substandard products or expired materials can compromise test performance. Several agencies determine the quality of laboratory work, and the College of American Pathologists plays a significant role in dictating laboratory standards and quality control procedures, which are essential to avoid different interfering factors.</p>
      </sec>
      <sec id="article-29415.s6" sec-type="Results, Reporting, and Critical Findings&#x0000d;&#x0000a;">
        <title>Results, Reporting, and Critical Findings
</title>
        <p>
<bold>Sputum Culture</bold>
</p>
        <p>The result is considered positive if the pathogenicity organisms grow after 24 hours of incubation in the culture dish.&#x000a0;<bold>Some sample dishes may require longer incubation times based on microbial flora, the need to identify semiquantitative isolates, and to perform antimicrobial susceptibility tests.&#x000a0;</bold>Conversely,&#x000a0;a negative result is determined if no bacteria or fungi grow in 6 to 8 weeks for solid culture media or&#x000a0;6 weeks for liquid culture media.&#x000a0;</p>
        <p>
<bold>Sputum Staining Tests</bold>
</p>
        <p><bold>Gram stain test:</bold>&#x000a0;This test detects whether the bacteria are Gram-positive or Gram-negative.</p>
        <list list-type="bullet">
          <list-item>
            <p>Common Gram-positive bacteria include <italic toggle="yes">Staphylococcus</italic>, <italic toggle="yes">Streptococcus</italic>, <italic toggle="yes">Bacillus</italic>,<italic toggle="yes"> Listeria</italic>, <italic toggle="yes">Enterococcus</italic>, and <italic toggle="yes">Clostridium.</italic></p>
          </list-item>
          <list-item>
            <p>Common Gram-negative bacteria include <italic toggle="yes">Escherichia</italic>
<italic toggle="yes">coli</italic>, <italic toggle="yes">Klebsiella species</italic>, <italic toggle="yes">Proteus species</italic>, and <italic toggle="yes">Pseudomonas aeruginosa.</italic></p>
          </list-item>
        </list>
        <p><bold>Acid-fast bacilli stain test:</bold>&#x000a0;This test determines whether&#x000a0;the bacteria are AFB-positive or AFB-negative.</p>
        <list list-type="bullet">
          <list-item>
            <p>AFB-positive result: AFB, such as <italic toggle="yes">Mycobacterium tuberculosis</italic>,&#x000a0;retain a red or pink color.</p>
          </list-item>
          <list-item>
            <p>AFB-negative result: No red or pink bacteria&#x000a0;are observed on the stained slide.</p>
          </list-item>
        </list>
        <p><bold>Grocott-Gomori's methenamine silver stain test:</bold> This test determines whether fungal organisms are present, yielding a positive or negative result.</p>
        <list list-type="bullet">
          <list-item>
            <p>GMS test positive result: Black or brown walls are observed from fungal organisms or worms such as&#x000a0;<italic toggle="yes"><italic toggle="yes">Pneumocystis jirovecii</italic>.</italic></p>
          </list-item>
          <list-item>
            <p>GMS test negative&#x000a0;result: No black or brown stained fungal organisms or worms&#x000a0;are observed.</p>
          </list-item>
        </list>
        <p><bold>Sputum Biochemical Tests:</bold> The motility, McFarland standard, catalase, and&#x000a0;oxidase&#x000a0;tests&#x000a0;are&#x000a0;positive or negative.</p>
        <p><bold>Motility test:</bold>&#x000a0;The test is used for Gram-negative enteric bacilli to determine whether organisms are motile or nonmotile.</p>
        <list list-type="bullet">
          <list-item>
            <p>Motile (positive): Organisms spread out from the stab line, producing cloudiness or turbidity throughout the medium.</p>
          </list-item>
          <list-item>
            <p>Nonmotile (negative): Organisms remain along the stab line of inoculation.</p>
          </list-item>
        </list>
        <p><bold>McFarland standard test:</bold>&#x000a0;This test is used to standardize the bacterial concentration in liquid suspensions by comparing the turbidity of bacteria in the McFarland standard vial or tube. The test results are obtained by comparing the turbidity of a bacterial suspension with different concentrations&#x000a0;of&#x000a0;McFarland standard solutions.</p>
        <p><bold>Fluid thioglycollate medium test:</bold>&#x000a0;The test is used&#x000a0;to detect&#x000a0;the aerotolerance of bacteria.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Obligate aerobes, such as <italic toggle="yes">Pseudomonas </italic>species, require oxygen for growth and only grow toward the oxygen-rich surface layer.</p>
          </list-item>
          <list-item>
            <p>Obligate anaerobes cannot grow in the presence of oxygen and only grow at the bottom of the tube.</p>
          </list-item>
          <list-item>
            <p>Microaerophiles frequently grow below the oxygen-rich&#x000a0;layer.</p>
          </list-item>
          <list-item>
            <p>Gram-negative, facultative, or aerotolerant anaerobes can generally grow throughout the broth but mostly grow between the oxygen-rich and oxygen-free areas.</p>
          </list-item>
        </list>
        <p><bold>Catalase test:</bold> The test is used to differentiate staphylococci from streptococci by detecting the presence&#x000a0;of catalase.</p>
        <list list-type="bullet">
          <list-item>
            <p>Catalase-positive: The organisms can produce catalase, which generates oxygen bubbles after adding&#x000a0;3% hydrogen peroxide.</p>
          </list-item>
          <list-item>
            <p>Catalase-negative: The organisms cannot produce catalase,&#x000a0;and there is no reaction&#x000a0;after adding 3% hydrogen peroxide.</p>
          </list-item>
        </list>
        <p><bold>Oxidase test:</bold> The test is used to detect the presence of&#x000a0;cytochrome c oxidases.</p>
        <list list-type="bullet">
          <list-item>
            <p>Oxidase-positive: There is&#x000a0;a deep purple-blue&#x000a0;or blue color change within 10&#x000a0;to 30 seconds.</p>
          </list-item>
          <list-item>
            <p>Oxidase-negative: No color change is observed.</p>
          </list-item>
        </list>
        <p><bold>Sputum nucleic acid amplification test: </bold>The result is positive if the RT-PCR amplification is successful. However, if it&#x000a0;is not successful, the result is negative.</p>
        <p><bold>Sputum cytology examination:&#x000a0;</bold>If a few white blood cells&#x000a0;and no abnormal cells&#x000a0;have been found in the sputum sample, the sputum cytology examination is regular, and other reasons may cause the patient's symptoms.</p>
        <p><bold>Sputum antimicrobial susceptibility test:&#x000a0;</bold>If antibiotics inhibit the organism's growth, they effectively treat&#x000a0;the infection, indicating susceptibility. Conversely, if the antibiotic does not inhibit the organism's growth, the&#x000a0;antibiotics are not adequate for the patient's treatment and are resistant.</p>
      </sec>
      <sec id="article-29415.s7" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Sputum analysis is essential&#x000a0;for discovering the causes of different airway and lung diseases. An accurate diagnosis is directly related to the clinician's treatment strategy. For infectious diseases, a lab technician first tries to find the pathogens and then tests different drugs that can be used for treatment. The lab inspects whether abnormal cells exist in the sputum specimens for suspected lung cancers and certain non-cancerous lung conditions.</p>
      </sec>
      <sec id="article-29415.s8" sec-type="Quality Control and Lab Safety&#x0000d;&#x0000a;">
        <title>Quality Control and Lab Safety
</title>
        <p>Quality control in sputum analysis is essential to ensure accurate diagnostic results. Every step&#x02014;from specimen collection, transport, and storage to test procedure environments and result reporting&#x02014;should strictly follow standardized guidelines. In 1988, the United States Congress passed the Clinical Laboratory Improvement Amendments. The Clinical and Laboratory Standards Institute was established to minimize the analysis errors and maximize the control of test variables. Similar regulations are present in other countries. A standard positive, sensitivity and negative control should always be performed during the diagnostic tests when the laboratory technician carries out&#x000a0;the sputum sample tests. No diagnostic results should be reported&#x000a0;when quality control measurements are not authorized.&#x000a0;</p>
        <p>Laboratory staff must adhere to strict safety protocols.&#x000a0;Depending on specific&#x000a0;diagnostic tests,&#x000a0;the procedural risk assessment results may differ. Sputum samples should always be considered potentially infectious, and essential biosafety measures should be set to limit or reduce the risks of laboratory infection when&#x000a0;specific procedures are&#x000a0;performed.&#x000a0;The&#x000a0;Clinical and Laboratory Standards Institute has provided new practice guidelines for applying risk management to quality control plans and statistical quality control.<xref ref-type="bibr" rid="article-29415.r18">[18]</xref><xref ref-type="bibr" rid="article-29415.r19">[19]</xref></p>
      </sec>
      <sec id="article-29415.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Sputum analysis plays a crucial role in diagnosing various conditions, including respiratory infections, lung cancers, and non-cancerous lung diseases. Pneumonia is the most common lung infection and can spread easily. Untreated pneumonia may lead to severe complications. Lung cancer is ranked the fourth&#x000a0;most commonly diagnosed malignancy in developed countries and the first in cancer-caused death worldwide.<xref ref-type="bibr" rid="article-29415.r20">[20]</xref>&#x000a0;Despite&#x000a0;the high incidence and mortality of pneumonia and lung cancer, the treatments are few.<xref ref-type="bibr" rid="article-29415.r21">[21]</xref><xref ref-type="bibr" rid="article-29415.r22">[22]</xref><xref ref-type="bibr" rid="article-29415.r23">[23]</xref>. Therefore, an interprofessional approach is essential to ensure patients receive the most appropriate evidence-based diagnosis, treatment, and healthcare support. This team includes&#x000a0;a laboratory diagnostic specialist, a radiologist, a&#x000a0;pulmonologist,&#x000a0;an infectious disease expert, a pharmacist, and a public health nurse.</p>
        <p>The pulmonologist or infectious disease expert orders the laboratory tests according to the patient's symptoms. A&#x000a0;nurse or a healthcare supporter collects the sputum sample and sends it to the clinical lab. The laboratory specialist conducts the diagnostic tests for the sputum specimen and reports the results. The radiologist may also need to carry out&#x000a0;a chest X-ray for the patient. When the clinician receives&#x000a0;the sputum diagnostic reportings, they may prescript the drugs for the patient's treatment. Then, the nurse performs the clinical therapy.</p>
        <p>Once the patient is discharged from the hospital, the nurse should educate the patient and family members on maintaining good health.&#x000a0;The pharmacist should monitor the outpatient therapy and ensure the patient follows the treatment.&#x000a0;When the patient has an allergy to some drugs&#x000a0;or difficulties obeying&#x000a0;the treatment, the pharmacist should report the situation to the&#x000a0;interprofessional team. A social worker may also provide financial and emotional support for the patient. Regular follow-up testing in the clinical lab and imaging studies are essential to monitor progress and adjust treatment as needed.</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>The multidisciplinary team approach&#x000a0;facilitates delivering high-quality healthcare services to&#x000a0;the patient. Previous evidence suggested that patients are more satisfied with the traditional care model and have improved&#x000a0;life quality if they&#x000a0;receive multidisciplinary care.<xref ref-type="bibr" rid="article-29415.r24">[24]</xref><xref ref-type="bibr" rid="article-29415.r25">[25]</xref></p>
      </sec>
      <sec id="article-29415.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29415&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29415">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29415/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29415">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29415.s11">
        <title>References</title>
        <ref id="article-29415.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Loo</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>DT</given-names>
              </name>
            </person-group>
            <article-title>Human body fluid proteome analysis.</article-title>
            <source>Proteomics</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>23</issue>
            <fpage>6326</fpage>
            <page-range>6326-53</page-range>
            <pub-id pub-id-type="pmid">17083142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beveridge</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Cellular responses of Bacillus subtilis and Escherichia coli to the Gram stain.</article-title>
            <source>J Bacteriol</source>
            <year>1983</year>
            <month>Nov</month>
            <volume>156</volume>
            <issue>2</issue>
            <fpage>846</fpage>
            <page-range>846-58</page-range>
            <pub-id pub-id-type="pmid">6195148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burns</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Emerson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kuypers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>McNamara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Worrell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Englund</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings.</article-title>
            <source>Influenza Other Respir Viruses</source>
            <year>2012</year>
            <month>May</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>218</fpage>
            <page-range>218-23</page-range>
            <pub-id pub-id-type="pmid">21955319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harju</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Leinonen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nokso-Koivisto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Korhonen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>R&#x000e4;ty</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Hovi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mertsola</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bloigu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rytil&#x000e4;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Saikku</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma.</article-title>
            <source>Thorax</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>61</volume>
            <issue>7</issue>
            <fpage>579</fpage>
            <page-range>579-84</page-range>
            <pub-id pub-id-type="pmid">16517571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rohde</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wiethege</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Borg</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kauth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Gillissen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bufe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schultze-Werninghaus</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.</article-title>
            <source>Thorax</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-42</page-range>
            <pub-id pub-id-type="pmid">12511718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muller</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>McGeer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Severe acute respiratory syndrome (SARS) coronavirus.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>201</fpage>
            <page-range>201-12</page-range>
            <pub-id pub-id-type="pmid">17458774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mulrennan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tempone</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>IT</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Gan</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Speers</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable.</article-title>
            <source>PLoS One</source>
            <year>2010</year>
            <month>Sep</month>
            <day>21</day>
            <volume>5</volume>
            <issue>9</issue>
            <fpage>e12849</fpage>
            <pub-id pub-id-type="pmid">20877727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Assiri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al-Tawfiq</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Al-Rabeeah</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Al-Rabiah</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Al-Hajjar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Al-Barrak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Flemban</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Al-Nassir</surname>
                <given-names>WN</given-names>
              </name>
              <name>
                <surname>Balkhy</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Al-Hakeem</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Makhdoom</surname>
                <given-names>HQ</given-names>
              </name>
              <name>
                <surname>Zumla</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Memish</surname>
                <given-names>ZA</given-names>
              </name>
            </person-group>
            <article-title>Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>9</issue>
            <fpage>752</fpage>
            <page-range>752-61</page-range>
            <pub-id pub-id-type="pmid">23891402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mawaddah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gendeh</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lum</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Marina</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Upper respiratory tract sampling in COVID-19.</article-title>
            <source>Malays J Pathol</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-35</page-range>
            <pub-id pub-id-type="pmid">32342928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burnett</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Sergi</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Face Masks Are Beneficial Regardless of the Level of Infection in the Fight Against COVID-19.</article-title>
            <source>Disaster Med Public Health Prep</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>e47</fpage>
            <page-range>e47-e50</page-range>
            <pub-id pub-id-type="pmid">32900420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Titford</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The long history of hematoxylin.</article-title>
            <source>Biotech Histochem</source>
            <year>2005</year>
            <season>Mar-Apr</season>
            <volume>80</volume>
            <issue>2</issue>
            <fpage>73</fpage>
            <page-range>73-8</page-range>
            <pub-id pub-id-type="pmid">16195172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosai</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Why microscopy will remain a cornerstone of surgical pathology.</article-title>
            <source>Lab Invest</source>
            <year>2007</year>
            <month>May</month>
            <volume>87</volume>
            <issue>5</issue>
            <fpage>403</fpage>
            <page-range>403-8</page-range>
            <pub-id pub-id-type="pmid">17401434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanahan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Hallmarks of cancer: the next generation.</article-title>
            <source>Cell</source>
            <year>2011</year>
            <month>Mar</month>
            <day>04</day>
            <volume>144</volume>
            <issue>5</issue>
            <fpage>646</fpage>
            <page-range>646-74</page-range>
            <pub-id pub-id-type="pmid">21376230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeuchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Soda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Inamura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Togashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hatano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Enomoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Satoh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Okumura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mano</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.</article-title>
            <source>Clin Cancer Res</source>
            <year>2008</year>
            <month>Oct</month>
            <day>15</day>
            <volume>14</volume>
            <issue>20</issue>
            <fpage>6618</fpage>
            <page-range>6618-24</page-range>
            <pub-id pub-id-type="pmid">18927303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Settleman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Haber</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Epidermal growth factor receptor mutations in lung cancer.</article-title>
            <source>Nat Rev Cancer</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>169</fpage>
            <page-range>169-81</page-range>
            <pub-id pub-id-type="pmid">17318210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsu</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>YC</given-names>
              </name>
            </person-group>
            <article-title>Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.</article-title>
            <source>J Pathol</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>213</volume>
            <issue>4</issue>
            <fpage>412</fpage>
            <page-range>412-9</page-range>
            <pub-id pub-id-type="pmid">17973238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hubers</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Prinsen</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Sozzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Thunnissen</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Molecular sputum analysis for the diagnosis of lung cancer.</article-title>
            <source>Br J Cancer</source>
            <year>2013</year>
            <month>Aug</month>
            <day>06</day>
            <volume>109</volume>
            <issue>3</issue>
            <fpage>530</fpage>
            <page-range>530-7</page-range>
            <pub-id pub-id-type="pmid">23868001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruno</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>IQCP: Guideline and Helpful Tools for Implementation.</article-title>
            <source>Lab Med</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>e42</fpage>
            <page-range>e42-e46</page-range>
            <pub-id pub-id-type="pmid">27708173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The Individualized Quality Control Plan - Coming Soon to Clinical Microbiology Laboratories Everywhere!</article-title>
            <source>Clin Microbiol Newsl</source>
            <year>2015</year>
            <month>Nov</month>
            <day>15</day>
            <volume>37</volume>
            <issue>22</issue>
            <fpage>177</fpage>
            <page-range>177-185</page-range>
            <pub-id pub-id-type="pmid">26997689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horton</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>GBD 2010: understanding disease, injury, and risk.</article-title>
            <source>Lancet</source>
            <year>2012</year>
            <month>Dec</month>
            <day>15</day>
            <volume>380</volume>
            <issue>9859</issue>
            <fpage>2053</fpage>
            <page-range>2053-4</page-range>
            <pub-id pub-id-type="pmid">23245595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hickling</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A retrospective survey of treatment and mortality in aspiration pneumonia.</article-title>
            <source>Intensive Care Med</source>
            <year>1988</year>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>617</fpage>
            <page-range>617-22</page-range>
            <pub-id pub-id-type="pmid">3053842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Komiya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Umeki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mizunoe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Johkoh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kadota</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcare-associated pneumonia: a multicenter retrospective cohort study.</article-title>
            <source>Respirology</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>514</fpage>
            <page-range>514-21</page-range>
            <pub-id pub-id-type="pmid">23231701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denton</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Conron</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Improving outcomes in lung cancer: the value of the multidisciplinary health care team.</article-title>
            <source>J Multidiscip Healthc</source>
            <year>2016</year>
            <volume>9</volume>
            <fpage>137</fpage>
            <page-range>137-44</page-range>
            <pub-id pub-id-type="pmid">27099511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griffin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Cooley</surname>
                <given-names>ME</given-names>
              </name>
              <collab>American College of Chest Physicians</collab>
            </person-group>
            <article-title>Palliative care consultation, quality-of-life measurements, and bereavement for end-of-life care in patients with lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).</article-title>
            <source>Chest</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>132</volume>
            <issue>3 Suppl</issue>
            <fpage>404S</fpage>
            <page-range>404S-422S</page-range>
            <pub-id pub-id-type="pmid">17873182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29415.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirsch-Moverman</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Frederix</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lebelo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hesseling</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nachman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mantell</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Lekhela</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maama</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>El-Sadr</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial.</article-title>
            <source>Trials</source>
            <year>2017</year>
            <month>Nov</month>
            <day>21</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>552</fpage>
            <pub-id pub-id-type="pmid">29157275</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
